Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 2OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Neuroblastoma 2Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Ototoxicity 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, B-Cell 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Hepatoblastoma 1Graft vs Host Disease 1Esophageal Squamous Cell Carcinoma 1Burkitt Lymphoma 1

Interventions

Vincristine 1Rituximab 1Methotrexate 1Doxorubicin 1Cytarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Has announcements × Burkitt Lymphoma × Clear all
NCT01516580 2026-02-09

Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed
482 enrolled 1 FDA
Lymphoid

Burkitt Lymphoma, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡